publication date: Dec. 18, 2010

In this issue: 

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

Patients “Raise A Voice” For Provenge Approval.

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

Download (PDF 712KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.